跳到正文
原文
MedTech Dive 器械媒体· Elise Reuter·· 2026-10-16AI 评分42

MiniMed完成与Medtronic的分离

MiniMed completes separation from Medtronic

AI 导读

MiniMed已完成与母公司Medtronic的分离,成为独立运营的公司。Medtronic选择将其持有的全部MiniMed剩余股份换取Medtronic股份,因该要约认购率为5.4倍,Medtronic不再持有MiniMed股权。MiniMed股价周四收于17.50美元。

正文

MiniMed completed its separation from Medtronic, the companies said Thursday.

The diabetes technology firm, which went public in March, is now independent from its former parent. 

Medtronic began an exchange offer last month to split off a portion of its MiniMed shares. The agreement included a provision where Medtronic could choose to sell all of its remaining shares in MiniMed if the offer is oversubscribed.

Because the offer was 5.4x subscribed, Medtronic chose to exchange all of its remaining interest in MiniMed for shares of Medtronic, the company said Thursday. It no longer holds a stake in MiniMed. 

“As an independent company, we have the freedom to make the decisions we believe are right for our business and the people we serve, and the responsibility to see those decisions through,” MiniMed CEO Que Dallara said in a statement. “Our focus now is to put that independence to work and continue advancing what is possible in diabetes care." 

Shares of MiniMed closed at $17.50 on Thursday.

CFO Chad Spooner said in an earnings call last month that the company is working to exit technology service agreements with Medtronic. MiniMed started with about 160 such agreements and expects to exit most of them in 2027.

来源:MedTech Dive 器械媒体 · medtechdive.com